REYON Pharmaceutical Co., Ltd. (102460.KS) KSC
9,990.00
-210(-2.06%)
Currency In KRW
- General
- Statistics
- Historical Data
- Profile
- Financials
9,990.00
-210(-2.06%)
Currency In KRW
| Market Cap | 200.37B |
| Enterprise Value | 409.82B |
| P/E Ratio | -4.49 |
| PEG Ratio | 0.05 |
| Price/Sales Ratio | 1.26 |
| Price/Book Ratio | 0.87 |
| Enterprise/Revenue | 2.74 |
| Enterprise/EBITDA | -159.79 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -0.28 |
| Operating Margin | -0.23 |
| Return On Assets | -0.09 |
| Return On Equity | -0.18 |
| Revenue | 145.93B |
| Revenue/Share | 7,917.87 |
| Gross Profit | 33.76B |
| EBITDA | 228.1M |
| Net Income | -29.83B |
| Diluted EPS | -1,604.66 |
| Total Cash | 4.35B |
| Total Cash/Share | 237.22 |
| Total Debt | 219.17B |
| Total Debt/Equity | 1.05 |
| Current Ratio | 0.52 |
| Book Value Per Share | 11,427.07 |
| 52-Week Change | -8.35 |
| 52-Week High | 14,430 |
| 52-Week Low | 9,580 |
| Moving Average 50 Days | 10,703.6 |
| Moving Average 200 Days | 11,048.9 |
| Average Volume | 90,575 |
| Shares Outstanding | 18.34M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 51:50 |
| Last Split Date | December 29, 2020 |